Structural basis of receptor recognition by SARS-CoV-2

2020/03/30 by Jian Shang, Gang Ye, Ke Shi +7 · 21 citations
Medicine · #COVID-19 Clinical Research Studies #SARS-CoV-2 and COVID-19 Research #Viral gastroenteritis research and epidemiology

paper · pdf · doi:10.1038/s41586-020-2179-y

crossref issued 2020/03/30 · crossref published 2020/03/30 · crossref published-online 2020/03/30 · openalex publication_date 2020/03/30 · crossref created 2020/03/30 · crossref published-print 2020/05/14 · crossref deposited 2023/05/20 · openalex created_date 2025/10/10 · crossref indexed 2026/07/31 · openalex updated_date 2026/07/31

Citations

• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
• Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
• A pneumonia outbreak associated with a new coronavirus of probable bat origin
• Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
• Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
• Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
• Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
• Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Cited by

• Mechanisms of SARS-CoV-2 entry into cells
• The trinity of COVID-19: immunity, inflammation and intervention
• Vaccination protects against COVID-associated pulmonary fibrin deposition
• Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
• Coronavirus biology and replication: implications for SARS-CoV-2
• Characteristics of SARS-CoV-2 and COVID-19
• SARS-CoV-2 uses CD4 to infect T helper lymphocytes
• Intravenous SARS-CoV-2 Spike protein induces neuroinflammation and alpha-Synuclein accumulation in brain regions relevant to Parkinson’s disease
• ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023
• Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
• The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2
• SARS-CoV-2 damages cardiomyocyte mitochondria and implicates long COVID-associated cardiovascular manifestations
• Extrapulmonary manifestations of COVID-19
• SARS-CoV-2 (COVID-19) by the numbers
• COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
• A review on antiviral and immunomodulatory polysaccharides from Indian medicinal plants, which may be beneficial to COVID-19 infected patients
• Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor
• Viroinformatics-based investigation of SARS-CoV-2 core proteins for potential therapeutic targets
• Predicting potential drug targets and repurposable drugs for COVID-19 via a deep generative model for graphs
• Post-acute COVID-19 syndrome
• Human organoids: model systems for human biology and medicine
• The UniProt website API: facilitating programmatic access to protein knowledge